PKP2 truncating variants in ARVC cohorts


The table below lists the 95 rare (MAF<0.0001 in ExAC) truncating PKP2 variants identified in a cohort of 361 ARVC patients. When this rare variant frequency of 0.26316 is compared with a background population rate of 0.00076, there is a statistically significant case excess of 0.26240 (p<0.0001), which suggests that approximately 95 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      OMGL



No. Variant (CDS) Variant (Protein) Variant Type Cases (361)OMGL class ExAC frequency
1. c.148_151delACAG p.Thr50SerfsX61frameshift 2Pathogenic0.000000
2. c.215del p.Val72Glyfs*40frameshift 1Pathogenic0.000000
3. c.235C>T p.R79Xnonsense 1Pathogenic0.000000
4. c.253_256delGAGT frameshift 1Pathogenic0.000000
5. c.275T>A p.L92Xnonsense 3Pathogenic0.000000
6. c.314del p.Pro105Leufs*7frameshift 1Pathogenic0.000000
7. c.337-2A>T essential splice site 2Pathogenic0.000000
8. c.356dup p.Tyr119*frameshift 1Pathogenic0.000000
9. c.358G>T p.E120Xnonsense 2Pathogenic0.000000
10. c.663C>A p.Y221Xnonsense 1Pathogenic0.000008
11. c.775G>T p.E259Xnonsense 1Pathogenic0.000000
12. c.968_975delinsGCCTTT p.Gln323Argfs*12frameshift 1Pathogenic0.000000
13. c.1063C>T p.R355Xnonsense 1Pathogenic0.000008
14. c.1101dup p.Ser368Ilefs*19frameshift 1Pathogenic0.000000
15. c.1125_1132del p.Phe376Alafs*8frameshift 1Pathogenic0.000000
16. c.1132C>T p.Q378Xnonsense 3Pathogenic0.000000
17. c.1170+1G>C essential splice site 1Pathogenic0.000000
18. c.1171_1378del p.Val391Thrfs*6frameshift 1Likely Pathogenic0.000000
19. c.1177C>T p.Q393Xnonsense 1Pathogenic0.000000
20. c.1211dup p.Val406Serfs*4frameshift 1Pathogenic0.000000
21. c.1237C>T p.R413Xnonsense 2Pathogenic0.000016
22. c.1255_1279dup p.Asn427Ilefs*7frameshift 1Likely Pathogenic0.000000
23. c.1372_1375del p.Ile458Glnfs*7frameshift 1Pathogenic0.000000
24. c.1689-1G>C essential splice site 1Pathogenic0.000008
25. c.1748_1755dup p.Val587Thrfs*72frameshift 2Pathogenic0.000000
26. c.1754C>G p.S585Xnonsense 1Pathogenic0.000000
27. c.1892delinsTCC p.Tyr631Phefs*26frameshift 1Pathogenic0.000000
28. c.1901del p.Asn634Thrfs*22frameshift 2Pathogenic0.000000
29. c.1917_1935dup p.Gly646*frameshift 1Pathogenic0.000000
30. c.1968del p.Glu657Serfs*27frameshift 1Pathogenic0.000000
31. c.1999G>T p.E667Xnonsense 2Pathogenic0.000000
32. c.2058T>A p.Y686Xnonsense 1Pathogenic0.000000
33. c.2119C>T p.Q707Xnonsense 1Pathogenic0.000000
34. c.2146-1G>C essential splice site 24Pathogenic0.000049
35. c.2197_2202delinsG p.His733Alafs*8frameshift 16Pathogenic0.000000
36. c.2489+1G>A essential splice site 8Pathogenic0.000024
37. c.2490-1G>C essential splice site 1Pathogenic0.000000
38. c.2493T>A p.Y831Xnonsense 1Pathogenic0.000000
39. c.2509delA p.Ser837ValfsX94frameshift 1Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.